Evidence map›Paper›PMID 38006517›Full record

ArticleEcoHealth2023

Wildlife Consumption, Health, and Zoonotic Disease in China After the Emergence of COVID-19.

Jessica Bell Rizzolo, Annah Zhu, Ruishan Chen

Abstract read
PubMed Publisher
In one paragraph

Article in EcoHealth, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jessica Bell RizzoloDepartment of Fisheries, Wildlife, and Conservation Sciences, Oregon State University, Corvallis, OR, USA. jessica.b.rizzolo@gmail.com.
Annah ZhuEnvironmental Policy Group, Wageningen University, Wageningen, The Netherlands.
Ruishan ChenShanghai Jiaotong University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There has been much discussion in the conservation and policy realms of COVID-19 as a zoonotic disease, or a disease transmitted from wildlife to humans. However, wildlife consumption in China is not only a potential source of disease but also a practice embedded in complex beliefs about health. This paper used survey data (N = 974) collected in China in June 2021 to examine attitudes and behaviors related to (a) wildlife consumption, (b) Traditional Chinese Medicine (TCM) and (c) zoonotic risk after the emergence of the COVID-19 pandemic. 40.1% of respondents self-reported that they are less likely to consume wild animals since the outbreak of COVID-19. Respondents who used wildlife supplements for TCM, who believed in the benefits of wild animal consumption and fresh slaughter of wildlife, and who had higher levels of agreement with the zoonotic origin of COVID-19 were more likely to report that they had decreased their wildlife consumption after the outbreak of COVID-19. Use of wildlife in TCM significantly increased the odds that a respondent believed that COVID-19 was very likely zoonotic. We discuss how situating wildlife consumption within complex beliefs about health and disease can assist with protecting wildlife and public health in the wake of COVID-19.

Indexed as

Animals, WildCOVID-19AnimalsChinaHumansPandemicsZoonosesBatPandemicPangolinTraditional Chinese MedicineWet marketWildlife farm

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.